The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain

Emilio Giugliano, Giugliano E, Cagnazzo E, Elisa Cagnazzo, Ilaria Soave, Soave I, Lo Monte G, Giuseppe Lo Monte, Jean Marie Wenger, Wenger JM, Roberto Marci
European journal of obstetrics, gynecology, and reproductive biology · 2013 · vol. 168(2) , pp. 209–213 · doi:10.1016/j.ejogrb.2013.01.009 · PMID:23415738 · W2138898702
article OA: closed CC0 ⤵ 19 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study investigated the efficacy of N-palmitoylethanolamine and transpolydatin as adjuvant treatments for endometriotic pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo test the adjuvant use of the combination of N-palmitoylethanolamine and transpolydatin in the medical treatment of endometriotic pain.Study designWe enrolled 47 patients admitted to the Outpatient Endometriosis Care Unit of Ferrara University from January 2011 to December 2011. They were divided into two groups according to the endometriosis site (group A: recto-vaginal septum; group B: ovary). One tablet, containing 400 mg of micronized N-palmitoylethanolamine plus 40 mg transpolydatin, was administered twice daily on a full stomach for 90 days. Each patient was requested to grade the severity of dysmenorrhea, chronic pelvic pain, dyspareunia and dyschezia using a 0-10 cm visual analogic scale prior to beginning treatment (T0), after 30 days (T1), 60 days (T2) and 90 days (T3). The continuous and categorical variables were compared, respectively, using Student's t-test and the chi-square test. Analysis of variance for repeated measures was used to verify the reduction of endometriotic pain.ResultsThe intensity of endometriotic pain decreased significantly for both groups (p<0.0001). The efficacy of drug treatment was significant after 30 days. Pain intensity decreased equally in the two groups except for dysmenorrhea, which was reduced more rapidly in group B.ConclusionsThe combination of N-palmitoylethanolamine and transpolydatin reduced pain related to endometriosis irrespective of lesion site. It had a marked effect on chronic pelvic pain determined by deep endometriosis and on dysmenorrhea correlated to ovarian endometriosis.

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosischronic_pelvic_pain

MeSH descriptors

Anti-Inflammatory Agents, Non-Steroidal Endocannabinoids Endometriosis Ethanolamines Female Urogenital Diseases Glucosides Palmitic Acids Pelvic Pain Stilbenes Adult Amides Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Chronic Pain Chronic Pain Chronic Pain Contraceptives, Oral, Combined Contraceptives, Oral, Combined Drug Combinations Drug Therapy, Combination

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Cited by (20)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:12.052662+00:00
unpaywall
last seen: 2026-07-25T06:54:40.737861+00:00
License: CC0 · commercial use OK